Review



rabbit polyclonal antibody against human cd133  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    Proteintech rabbit polyclonal antibody against human cd133
    Correlations among intravascular emboli (IVE), <t> CD133 </t> expression and clinicopathological characteristics.
    Rabbit Polyclonal Antibody Against Human Cd133, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 340 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal antibody against human cd133/product/Proteintech
    Average 96 stars, based on 340 article reviews
    rabbit polyclonal antibody against human cd133 - by Bioz Stars, 2026-03
    96/100 stars

    Images

    1) Product Images from "Intravascular emboli is an independent risk factor for the prognosis of stage III colorectal cancer patients after radical surgery"

    Article Title: Intravascular emboli is an independent risk factor for the prognosis of stage III colorectal cancer patients after radical surgery

    Journal: Oncotarget

    doi: 10.18632/oncotarget.11266

    Correlations among intravascular emboli (IVE), CD133 expression and clinicopathological characteristics.
    Figure Legend Snippet: Correlations among intravascular emboli (IVE), CD133 expression and clinicopathological characteristics.

    Techniques Used: Expressing

    A , B . Positive expression of CD133 in IVE colorectal cancer tissue: CD34 IHC staining marked the blood vessel endothelium (red arrow), and IVE was strongly stained by CD133 antibody (black arrow); C , D . CD133-negative expression in IVE colorectal cancer tissue: CD34 IHC staining marked the blood vessel endothelium (red arrow); IVE was not stained by the CD133 antibody (black arrow); E . Positive expression of CD133 in non-IVE colorectal cancer tissue (black arrow); F. CD133-negative expression in non-IVE colorectal cancer tissue (black arrow).
    Figure Legend Snippet: A , B . Positive expression of CD133 in IVE colorectal cancer tissue: CD34 IHC staining marked the blood vessel endothelium (red arrow), and IVE was strongly stained by CD133 antibody (black arrow); C , D . CD133-negative expression in IVE colorectal cancer tissue: CD34 IHC staining marked the blood vessel endothelium (red arrow); IVE was not stained by the CD133 antibody (black arrow); E . Positive expression of CD133 in non-IVE colorectal cancer tissue (black arrow); F. CD133-negative expression in non-IVE colorectal cancer tissue (black arrow).

    Techniques Used: Expressing, Immunohistochemistry, Staining

    Univariate and multivariate analysis of 323 CRC patients for OS and DFS
    Figure Legend Snippet: Univariate and multivariate analysis of 323 CRC patients for OS and DFS

    Techniques Used: Expressing



    Similar Products

    rabbit polyclonal antibody against human cd133  (Proteintech)
    96
    Proteintech rabbit polyclonal antibody against human cd133
    Correlations among intravascular emboli (IVE), <t> CD133 </t> expression and clinicopathological characteristics.
    Rabbit Polyclonal Antibody Against Human Cd133, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal antibody against human cd133/product/Proteintech
    Average 96 stars, based on 1 article reviews
    rabbit polyclonal antibody against human cd133 - by Bioz Stars, 2026-03
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    Correlations among intravascular emboli (IVE), CD133 expression and clinicopathological characteristics.

    Journal: Oncotarget

    Article Title: Intravascular emboli is an independent risk factor for the prognosis of stage III colorectal cancer patients after radical surgery

    doi: 10.18632/oncotarget.11266

    Figure Lengend Snippet: Correlations among intravascular emboli (IVE), CD133 expression and clinicopathological characteristics.

    Article Snippet: After blocking with 3% BSA, the sections were incubated with rabbit polyclonal antibody against human CD133 at a dilution of 1:200 (18470-1-AP, Proteintech, China) overnight at 4°C, and this was followed by incubation with secondary antibody for 50 minutes at room temperature.

    Techniques: Expressing

    A , B . Positive expression of CD133 in IVE colorectal cancer tissue: CD34 IHC staining marked the blood vessel endothelium (red arrow), and IVE was strongly stained by CD133 antibody (black arrow); C , D . CD133-negative expression in IVE colorectal cancer tissue: CD34 IHC staining marked the blood vessel endothelium (red arrow); IVE was not stained by the CD133 antibody (black arrow); E . Positive expression of CD133 in non-IVE colorectal cancer tissue (black arrow); F. CD133-negative expression in non-IVE colorectal cancer tissue (black arrow).

    Journal: Oncotarget

    Article Title: Intravascular emboli is an independent risk factor for the prognosis of stage III colorectal cancer patients after radical surgery

    doi: 10.18632/oncotarget.11266

    Figure Lengend Snippet: A , B . Positive expression of CD133 in IVE colorectal cancer tissue: CD34 IHC staining marked the blood vessel endothelium (red arrow), and IVE was strongly stained by CD133 antibody (black arrow); C , D . CD133-negative expression in IVE colorectal cancer tissue: CD34 IHC staining marked the blood vessel endothelium (red arrow); IVE was not stained by the CD133 antibody (black arrow); E . Positive expression of CD133 in non-IVE colorectal cancer tissue (black arrow); F. CD133-negative expression in non-IVE colorectal cancer tissue (black arrow).

    Article Snippet: After blocking with 3% BSA, the sections were incubated with rabbit polyclonal antibody against human CD133 at a dilution of 1:200 (18470-1-AP, Proteintech, China) overnight at 4°C, and this was followed by incubation with secondary antibody for 50 minutes at room temperature.

    Techniques: Expressing, Immunohistochemistry, Staining

    Univariate and multivariate analysis of 323 CRC patients for OS and DFS

    Journal: Oncotarget

    Article Title: Intravascular emboli is an independent risk factor for the prognosis of stage III colorectal cancer patients after radical surgery

    doi: 10.18632/oncotarget.11266

    Figure Lengend Snippet: Univariate and multivariate analysis of 323 CRC patients for OS and DFS

    Article Snippet: After blocking with 3% BSA, the sections were incubated with rabbit polyclonal antibody against human CD133 at a dilution of 1:200 (18470-1-AP, Proteintech, China) overnight at 4°C, and this was followed by incubation with secondary antibody for 50 minutes at room temperature.

    Techniques: Expressing